Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Platelets compensate for poor thrombin generation in type 3 von Willebrand disease.

Szanto T, Nummi V, Jouppila A, Brinkman HJM, Lassila R.

Platelets. 2019 Mar 5:1-9. doi: 10.1080/09537104.2019.1581922. [Epub ahead of print]

PMID:
30836803
2.

Hemostatic profile under fluid resuscitation during rivaroxaban anticoagulation: an in vitro survey.

Helin TA, Zuurveld M, Manninen M, Meijers JCM, Lassila R, Brinkman HJM.

Transfusion. 2018 Dec;58(12):3014-3026. doi: 10.1111/trf.14933. Epub 2018 Oct 21.

PMID:
30343500
3.

Use of DOAC Stop for elimination of anticoagulants in the thrombin generation assay.

Kopatz WF, Brinkman HJM, Meijers JCM.

Thromb Res. 2018 Oct;170:97-101. doi: 10.1016/j.thromres.2018.08.014. Epub 2018 Aug 23.

PMID:
30149286
4.

Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment.

Pitkänen HH, Kärki M, Niinikoski H, Tanner L, Näntö-Salonen K, Pikta M, Kopatz WF, Zuurveld M, Meijers JCM, Brinkman HJM, Lassila R.

Haemophilia. 2018 Sep;24(5):e312-e321. doi: 10.1111/hae.13543. Epub 2018 Aug 2.

PMID:
30070418
5.

Factors related to cigarette smoking and intent to quit among adolescent inpatients with psychiatric and substance use disorders.

Minami H, Bloom EL, Brinkman HR, Abrantes AM, Young CC, Brown RA.

Drug Alcohol Depend. 2018 May 1;186:215-218. doi: 10.1016/j.drugalcdep.2018.01.030. Epub 2018 Mar 26.

6.

Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders: Project mSMART MIND.

Minami H, Brinkman HR, Nahvi S, Arnsten JH, Rivera-Mindt M, Wetter DW, Bloom EL, Price LH, Vieira C, Donnelly R, McClain LM, Kennedy KA, D'Aquila E, Fine M, McCarthy DE, Graham Thomas J, Hecht J, Brown RA.

Contemp Clin Trials. 2018 Mar;66:36-44. doi: 10.1016/j.cct.2017.12.014. Epub 2017 Dec 27.

7.

Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.

Saadah NH, van der Meer PF, Brinkman HJM, de Korte D, Bontekoe IJ, Korsten HH, Middelburg RA, van der Bom JG, Schipperus MR.

Transfusion. 2017 Oct;57(10):2381-2389. doi: 10.1111/trf.14260. Epub 2017 Jul 20.

PMID:
28727139
8.

Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.

Brinkman HJ, Patiwael S, Tripathi S, Meijers JC.

Thromb Res. 2016 Mar;139:102-10. doi: 10.1016/j.thromres.2016.01.017. Epub 2016 Jan 25.

PMID:
26916304
9.

Global assays and the management of oral anticoagulation.

Brinkman HJ.

Thromb J. 2015 Feb 10;13:9. doi: 10.1186/s12959-015-0037-1. eCollection 2015.

10.

INR vs. thrombin generation assays for guiding VKA reversal: a retrospective comparison.

Herpers R, van Rossum AP, van Beem RT, Michel WM, Strijbis VJ, Strengers PF, Castel A, Brinkman HJ.

Clin Chem Lab Med. 2015 Jul;53(8):1227-36. doi: 10.1515/cclm-2014-0877.

PMID:
25720079
11.

Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma.

Pitkänen H, Jouppila A, Mowinckel MC, Lemponen M, Patiwael S, Sandset PM, Lassila R, Brinkman HJ.

Thromb Res. 2015 Jan;135(1):167-74. doi: 10.1016/j.thromres.2014.10.020. Epub 2014 Nov 4.

PMID:
25466844
12.

Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.

Dinkelaar J, Patiwael S, Harenberg J, Leyte A, Brinkman HJ.

Clin Chem Lab Med. 2014 Nov;52(11):1615-23. doi: 10.1515/cclm-2014-0307.

PMID:
24902009
13.

In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban.

Dinkelaar J, Molenaar PJ, Ninivaggi M, de Laat B, Brinkman HJ, Leyte A.

J Thromb Haemost. 2013 Jun;11(6):1111-8. doi: 10.1111/jth.12236.

14.

Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies.

Dienava-Verdoold I, Marchetti MR, te Boome LC, Russo L, Falanga A, Koene HR, Mertens K, Brinkman HJ.

Thromb Haemost. 2012 Mar;107(3):468-76. doi: 10.1160/TH11-07-0457. Epub 2012 Feb 8.

PMID:
22318644
15.

Factor seven activating protease (FSAP): does it activate factor VII?

Stavenuiter F, Dienava-Verdoold I, Boon-Spijker MG, Brinkman HJ, Meijer AB, Mertens K.

J Thromb Haemost. 2012 May;10(5):859-66. doi: 10.1111/j.1538-7836.2012.04619.x.

16.

Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity.

Dienava-Verdoold I, Boon-Spijker MG, de Groot PG, Brinkman HJ, Voorberg J, Mertens K, Derksen RH, de Laat B.

J Thromb Haemost. 2011 Apr;9(4):738-47. doi: 10.1111/j.1538-7836.2011.04212.x.

17.

Implementing neonatal screening for haemoglobinopathies in the Netherlands.

Bouva MJ, Mohrmann K, Brinkman HB, Kemper-Proper EA, Elvers B, Loeber JG, Verheul FE, Giordano PC.

J Med Screen. 2010;17(2):58-65. doi: 10.1258/jms.2010.009075.

PMID:
20660432
18.

How to ensure nutrition security in the global economic crisis to protect and enhance development of young children and our common future.

de Pee S, Brinkman HJ, Webb P, Godfrey S, Darnton-Hill I, Alderman H, Semba RD, Piwoz E, Bloem MW.

J Nutr. 2010 Jan;140(1):138S-42S. doi: 10.3945/jn.109.112151. Epub 2009 Nov 25.

PMID:
19939998
19.

High food prices and the global financial crisis have reduced access to nutritious food and worsened nutritional status and health.

Brinkman HJ, de Pee S, Sanogo I, Subran L, Bloem MW.

J Nutr. 2010 Jan;140(1):153S-61S. doi: 10.3945/jn.109.110767. Epub 2009 Nov 25.

PMID:
19939996
20.

Persistent factor VIII-dependent factor X activation on endothelial cells is independent of von Willebrand factor.

Brinkman HJ, van Mourik JA, Mertens K.

Blood Coagul Fibrinolysis. 2008 Apr;19(3):190-6. doi: 10.1097/MBC.0b013e3282faa8c1.

PMID:
18388497
21.

Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics.

Barwell J, Pangon L, Hodgson S, Georgiou A, Kesterton I, Slade T, Taylor M, Payne SJ, Brinkman H, Smythe J, Sebire NJ, Solomon E, Docherty Z, Camplejohn R, Homfray T, Morris JR.

J Med Genet. 2007 Aug;44(8):516-20. Epub 2007 May 4.

22.

Evidence against a major genetic basis for combined breast and colorectal cancer susceptibility.

Brinkman H, Barwell J, Rose S, Tinworth L, Sodha N, Langman C, Brooks L, Payne S, Fisher S, Rowan A, Tomlinson I, Hodgson S.

Clin Genet. 2006 Dec;70(6):526-9. No abstract available.

PMID:
17100999
23.

Proteolytic cleavage of protein S during the hemostatic response.

Brinkman HJ, Mertens K, van Mourik JA.

J Thromb Haemost. 2005 Dec;3(12):2712-20.

24.

Endothelial cell activation in thrombotic thrombocytopenic purpura (TTP): a prospective analysis.

Romani De Wit T, Fijnheer R, Brinkman HJ, Kersting S, Hene RJ, van Mourik JA.

Br J Haematol. 2003 Nov;123(3):522-7.

PMID:
14617018
25.

Von Willebrand factor targets IL-8 to Weibel-Palade bodies in an endothelial cell line.

Romani de Wit T, de Leeuw HP, Rondaij MG, de Laaf RT, Sellink E, Brinkman HJ, Voorberg J, van Mourik JA.

Exp Cell Res. 2003 May 15;286(1):67-74.

PMID:
12729795
26.

Phospholipid-binding domain of factor VIII is involved in endothelial cell-mediated activation of factor X by factor IXa.

Brinkman HJ, Mertens K, van Mourik JA.

Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):511-6.

PMID:
11884299
27.
28.

Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.

Wahab NA, Yevdokimova N, Weston BS, Roberts T, Li XJ, Brinkman H, Mason RM.

Biochem J. 2001 Oct 1;359(Pt 1):77-87.

29.

Assembly of multimeric von Willebrand factor directs sorting of P-selectin.

Hop C, Guilliatt A, Daly M, de Leeuw HP, Brinkman HJ, Peake IR, van Mourik JA, Pannekoek H.

Arterioscler Thromb Vasc Biol. 2000 Jul;20(7):1763-8.

PMID:
10894814
30.

Umbilical artery waveform analysis based on maximum, mean and mode velocity in early human pregnancy.

Ursem NT, Brinkman HJ, Struijk PC, Hop WC, Kempski MH, Keller BB, Wladimiroff JW.

Ultrasound Med Biol. 1998 Jan;24(1):1-7.

PMID:
9483765
31.

In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease.

Turecek PL, Gritsch H, Pichler L, Auer W, Fischer B, Mitterer A, Mundt W, Schlokat U, Dorner F, Brinkman HJ, van Mourik JA, Schwarz HP.

Blood. 1997 Nov 1;90(9):3555-67.

32.

Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Brinkman HJ, Koster P, Mertens K, van Mourik JA.

Biochem J. 1997 May 1;323 ( Pt 3):735-40.

33.

Interpersonal distance, body orientation, and touch: effects of culture, gender, and age.

Remland MS, Jones TS, Brinkman H.

J Soc Psychol. 1995 Jun;135(3):281-97.

PMID:
7650932
34.

Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA.

Fontijn R, Hop C, Brinkman HJ, Slater R, Westerveld A, van Mourik JA, Pannekoek H.

Exp Cell Res. 1995 Jan;216(1):199-207.

PMID:
7813621
35.

The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes.

Brinkman HJ, Mertens K, Holthuis J, Zwart-Huinink LA, Grijm K, van Mourik JA.

Br J Haematol. 1994 Jun;87(2):332-42.

PMID:
7947276
36.
37.
38.

The platelet glycoprotein Ia-IIa-associated Br-alloantigen system is expressed by cultured endothelial cells.

Giltay JC, Brinkman HJ, Vlekke A, Kiefel V, van Mourik JA, von dem Borne AE.

Br J Haematol. 1990 Aug;75(4):557-60.

PMID:
2207007
39.
41.

Polar secretion of von Willebrand factor by endothelial cells.

van Buul-Wortelboer MF, Brinkman HJ, Reinders JH, van Aken WG, van Mourik JA.

Biochim Biophys Acta. 1989 May 10;1011(2-3):129-33.

PMID:
2785404
42.
43.

Glycoproteins IIb and IIIa in K562 cells.

Giltay JC, Brinkman HJ, Modderman PW, Tetteroo PA, van Mourik JA.

Blood. 1988 Apr;71(4):1171-2. No abstract available.

44.

Reconstitution of the vascular wall in vitro. A novel model to study interactions between endothelial and smooth muscle cells.

van Buul-Wortelboer MF, Brinkman HJ, Dingemans KP, de Groot PG, van Aken WG, van Mourik JA.

Exp Cell Res. 1986 Jan;162(1):151-8.

PMID:
3940226
45.

Cigarette smoke impairs endothelial cell prostacyclin production.

Reinders JH, Brinkman HJ, van Mourik JA, de Groot PG.

Arteriosclerosis. 1986 Jan-Feb;6(1):15-23.

PMID:
3080000
46.

The role of thrombin in the regulation of the endothelial prostaglandin production.

de Groot PG, Brinkman HJ, Gonsalves MD, Van Mourik JA.

Biochim Biophys Acta. 1985 Sep 30;846(3):342-9.

PMID:
2994748
47.

Effectiveness of ear protection against impulse noise.

Brinkman H.

Scand Audiol Suppl. 1982;16:23-39. No abstract available.

PMID:
6962509
48.

Problems of fluid flow through swarms of particles and through macromolecules in solution.

BRINKMAN HC.

Research. 1949 Apr;2(4):190-4. No abstract available.

PMID:
18126669
49.

STUDIES ON THE REACTION OF THE PERITONEUM TO TRAUMA AND INFECTION.

Coller FA, Brinkman H.

Ann Surg. 1939 Jun;109(6):942-54. No abstract available.

Supplemental Content

Loading ...
Support Center